A-T support groups have been organized by all major A-T organizations, such as the Ataxia Telangiectasia Children's Project, the National Ataxia Foundation (NAF), and the Ataxia Telangiectasia Medical Research Foundation.
The decreased coordination of movements (ataxia) associated with A-T first becomes apparent when a child begins to walk, typically between 12 and 18 months of age.
When a child has primarily motor delays, conditions such as cerebral palsy, ataxia, spina bifida, spinal muscular atrophy (withering) and myopathy may be present.
Establishing a diagnosis for ataxia telangiectasia is most difficult in very young children, primarily because the full-blown syndrome is not yet apparent.
According to The University of Chicago's Jack Miller Center for Peripheral Neuropathy, celiac disease has also been shown to cause ataxia, a condition marked by jerky uncoordinated muscle movements.
Ataxia telangiectasia (A-T), also called Louis-Bar syndrome or cerebello-oculocutaneous telangiectasia, is a rare, inherited disease that attacks the neurological and immune systems of children.
Ataxia means poor coordination, and the telangiectasia are tiny, red spider blood vessels which develop in A-T patients, especially on the whites of the eyes and on the surface of the ears.
Variations that cause disease are called mutations and A-T results from a defective gene, the ATM gene (for ataxia telangiectasia, mutated), first identified in 1995.
Spasticity, muscle weakness, coordination, ataxia, and scoliosis are all significant impairments that affect the posture and mobility of children and adults with CP.
Its most effective use, however, is as a nerve tonic in paralysis agitans, locomotor ataxia, impotence and nervous exhaustion.